LivaNova PLC (LIVN) - Rasio tanggungan utang jangka dawa marang modal

LivaNova PLC (LIVN) develops automated circulation support systems that streamline surgical procedures. These complex devices are assembled on robotic lines utilizing computer vision, although innovation remains dependent on the involvement of leading medical professionals. The historical price action (separate_debt_long_eq) is currently at 0.26. Production stability is guaranteed by the rigorous selection of electronics suppliers and the maintenance of strategic component reserves.

The high technological complexity of manufacturing cardiopulmonary bypass machines requires significant capital expenditures for the environmental modernization of LivaNova PLC (LIVN) plants. Analyzing the long-term debt-to-equity chart, an investor assesses the ratio of liabilities with a maturity of over one year to equity, where an increase in this metric signals increased financial leverage and heightened risks in the event of declining operating revenue.